• Citer

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

par Di Leo, Angelo ;Chan, S;Paesmans, Marianne ;Friedrichs, Kay;Pinter, Tamas;Cocquyt, Veronique;Murray, Elizabeth;Bodrogi, István;Walpole, Euan;Lesperance, Bernard;Korec, Stefan;Crown, John;Simmonds, Peter;Von Minckwitz, G;Leroy, Jean-Yves;Durbecq, Virginie ;Isola, Jorma;Aapro, Matti;Piccart-Gebhart, Martine ;Larsimont, Denis
Référence Breast cancer research and treatment, 86, 3, page (197-206)
Publication Publié, 2004-08

Article révisé par les pairs

• Détails
• Contenu

Titre:	HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.
Auteur:	Di Leo, Angelo; Chan, S; Paesmans, Marianne; Friedrichs, Kay; Pinter, Tamas; Cocquyt, Veronique; Murray, Elizabeth; Bodrogi, István; Walpole, Euan; Lesperance, Bernard; Korec, Stefan; Crown, John; Simmonds, Peter; Von Minckwitz, G; Leroy, Jean-Yves; Durbecq, Virginie; Isola, Jorma; Aapro, Matti; Piccart-Gebhart, Martine; Larsimont, Denis
Informations sur la publication:	Breast cancer research and treatment, 86, 3, page (197-206)
Statut de publication:	Publié, 2004-08
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	c-erb B-2
	p-53
	topoisomerase II alpha
MeSH keywords:	Adolescent
	Adult
	Aged
	Antibiotics, Antineoplastic -- administration & dosage
	Antibiotics, Antineoplastic -- therapeutic use
	Antineoplastic Agents, Phytogenic -- administration & dosage
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- genetics
	Breast Neoplasms -- pathology
	Doxorubicin -- administration & dosage
	Doxorubicin -- therapeutic use
	Female
	Genes, erbB-2
	Genetic Markers
	Humans
	In Situ Hybridization, Fluorescence
	Male
	Middle Aged
	Patient Selection
	Predictive Value of Tests
	Retrospective Studies
	Survival Analysis
	Taxoids -- administration & dosage
	Taxoids -- therapeutic use
	Treatment Outcome
Note générale:	Clinical Trial
	Journal Article
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1023/B:BREA.0000036783.88387.47
	info:pii/5265412
	info:scp/4043131642
	info:pmid/15567936